Get the latest Science News and Discoveries

An immune exhaustion signature predicts prognosis and identifies patients with diffuse large B-cell lymphoma (DLBCL) who derive preferential benefit from chimeric antigen receptor (CAR)-T cell therapy

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Related news:

Scoring system could help doctors identify patients at high risk of intramyocardial hemorrhage and guide treatment and monitoring

AI-Designed Drug Makes Patients' Blood Look Biologically Younger, Study Shows

Rheumatoid arthritis: Timely diagnosis and early treatment initiation are key determinants of prognosis.